By the age of 70, individuals with BRCA1 mutations had an estimated breast cancer penetrance of 64.6% (95% CI = 59.5% to 69.4%), while those with BRCA2 mutations had a penetrance of 61.0% (95% CI = 48.1% to 72.5%). This evidence concerns the gene BRCA2 and breast cancer.